Print Friendly, PDF & Email

NCT/Study#

NCT03909412 /

IST-PRO2018-0531

Phase I Study of Carfilzomib-based Chemotherapy Mobilization for Autologous Stem Cell Transplantation in Multiple Myeloma

DISEASE GROUP:
Transplant
current phase:
Phase I
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: